We are live on ! Find out more
BAM

Byrne Asset Management Portfolio holdings

AUM $185M
1-Year Est. Return 41.05%
This Fund
S&P 500
This Quarter Est. Return
+6.46%
1 Year Est. Return
+41.05%
3 Year Est. Return
+116.14%
5 Year Est. Return
10 Year Est. Return
AUM
$154M
AUM Growth
+$13.8M
Cap. Flow
-$3.23M
Cap. Flow %
-2.1%
Top 10 Hldgs %
25.84%
Holding
654
New
90
Increased
110
Reduced
105
Closed
105

Top Buys

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$698K
2
KVUE icon
Kenvue
KVUE
+$557K
3
UL icon
Unilever
UL
+$533K
4
DIS icon
Walt Disney
DIS
+$488K
5
HPQ icon
HP
HPQ
+$298K

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$1.32M
2
GILD icon
Gilead Sciences
GILD
+$1.04M
3
UPS icon
United Parcel Service
UPS
+$1.01M
4
WY icon
Weyerhaeuser
WY
+$868K
5
PPL
PPL Corp
PPL
+$858K

Sector Composition

Rank Sector Weight
1 Technology 20.11%
2 Healthcare 12.67%
3 Financials 9.46%
4 Consumer Discretionary 8.72%
5 Communication Services 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PM icon
101
Philip Morris
PM
$295B
$231K 0.15%
2,370
+50
+2% +$4.78K
PCG icon
102
PG&E
PCG
$38.7B
0
MMM icon
103
3M
MMM
$94.3B
$226K 0.15%
2,699
+1,083
+67% +$92K
APD icon
104
Air Products & Chemicals
APD
$67.4B
$224K 0.15%
747
-13
-2% -$3.7K
PSA.PRL icon
105
Public Storage 4.625% Series L Preferred Share
PSA.PRL
$398M
$220K 0.14%
+10,000
New +$216K
TDY icon
106
Teledyne Technologies
TDY
$31.8B
$217K 0.14%
528
SBUX icon
107
Starbucks
SBUX
$121B
$201K 0.13%
2,025
BMY icon
108
Bristol-Myers Squibb
BMY
$131B
$199K 0.13%
3,110
-85
-3% -$5.7K
IBB icon
109
iShares Biotechnology ETF
IBB
$9.71B
$198K 0.13%
1,556
+4
+0.3% +$520
TGT icon
110
Target
TGT
$67.5B
-1,664
Closed -$247K
QSR icon
111
Restaurant Brands International
QSR
$25.8B
$190K 0.12%
2,445
-124
-5% -$8.95K
OEF icon
112
iShares S&P 100 ETF
OEF
$20.5B
$178K 0.12%
862
-103
-11% -$20K
KMB icon
113
Kimberly-Clark
KMB
$36.4B
$172K 0.11%
1,245
+50
+4% +$6.96K
SHAK icon
114
Shake Shack
SHAK
$2.85B
$166K 0.11%
2,130
+535
+34% +$34.4K
LLY icon
115
Eli Lilly
LLY
$1.05T
$164K 0.11%
349
ELV icon
116
Elevance Health
ELV
$85.5B
$162K 0.11%
365
-5
-1% -$2.31K
QQQ icon
117
Invesco QQQ Trust
QQQ
$482B
$159K 0.1%
430
-52
-11% -$17.5K
XLY icon
118
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.2B
-2,080
Closed -$159K
UNP icon
119
Union Pacific
UNP
$175B
$154K 0.1%
753
-25
-3% -$4.97K
JOE icon
120
St. Joe Company
JOE
$3.84B
$151K 0.1%
3,120
+380
+14% +$16.6K
TXT icon
121
Textron
TXT
$15.3B
-2,665
Closed -$176K
VICI icon
122
VICI Properties
VICI
$29.3B
$150K 0.1%
4,760
+50
+1% +$1.6K
PLUG icon
123
Plug Power
PLUG
$3B
$146K 0.09%
14,015
-4,085
-23% -$37.2K
SCHD icon
124
Schwab US Dividend Equity ETF
SCHD
$105B
-6,426
Closed -$154K
JKS
125
JinkoSolar
JKS
$895M
$139K 0.09%
3,125
+3,070
+5,582% +$139K

Similar funds

Byrne Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Byrne Asset Management held 654 positions worth $154M, up 9.8% from $140M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Byrne Asset Management's Q2 2023 filing shows 90 new, 110 increased, 105 reduced and 105 closed positions. Its largest new stake was Kenvue: 21,370 shares worth $565K. The largest sale was Procter & Gamble, an estimated $1.32M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Byrne Asset Management's largest Q2 2023 buy was Kenvue: 21,370 shares worth $565K.
  • Byrne Asset Management added most to Freeport-McMoran in Q2 2023, an estimated $698K increase.
  • Byrne Asset Management's biggest Q2 2023 reduction was Meta Platforms (Facebook), cutting an estimated $671K.
  • Byrne Asset Management fully exited Procter & Gamble in Q2 2023, selling an estimated $1.32M.
  • Byrne Asset Management's ten largest holdings make up 26% of its $154M portfolio in Q2 2023.
  • Byrne Asset Management opened 90 new positions and closed 105 in Q2 2023.
  • Byrne Asset Management's portfolio value rose 9.8% quarter-over-quarter to $154M.

Based on Byrne Asset Management's 13F filing for Q2 2023, filed 21 Jul 2023.